Education
About Us
Working with TipRanks
Follow Us
UG Healthcare Corp. Ltd. (SG:8K7)
SGX:8K7
8K7 Stock Chart & Stats
S$0.10
>-S$0.01(-3.23%)
At close: 4:00 PM EST
S$0.10
>-S$0.01(-3.23%)
Day’s Range― - ―
52-Week RangeS$0.09 - S$0.12
Previous CloseN/A
Volume145.10K
Average Volume (3M)131.00K
Market Cap
S$58.02M
Enterprise ValueS$82.08M
Total Cash (Recent Filing)S$45.13M
Total Debt (Recent Filing)S$28.46M
Price to Earnings (P/E)―
Beta0.76
Next Earnings
Aug 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding623,825,800
10 Day Avg. Volume276,890
30 Day Avg. Volume131,003
Financial Highlights & Ratios
PEG Ratio0.48
Price to Book (P/B)0.43
Price to Sales (P/S)0.47
P/FCF Ratio-8.39
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
High Revenue GrowthSustained top-line expansion of ~52% indicates the company is winning sales and gaining market traction. Durable revenue growth improves fixed-cost absorption in manufacturing, supports scale economics and capacity utilization, and creates optionality to fund margin improvements if cost control follows.
Integrated Manufacturing And DistributionOwning manufacturing plus distribution and branded channels gives structural advantages: control over supply, quicker go-to-market, and multiple revenue streams. Vertical integration helps protect margins and customer access versus pure resellers, improving resilience across demand cycles.
Relatively Strong Equity Base And Moderate LeverageA high equity ratio and low debt-to-equity provide financial stability and flexibility. This capital structure reduces refinancing risk, supports investment in capacity or product lines, and offers a buffer in downturns—important for a cyclical manufacturing business.
Bears Say
Negative Profitability MarginsPersistently negative operating and net margins show the company is not converting sales into sustainable profits. Without structural cost reduction or pricing power, ongoing margin weakness will limit retained earnings, constrain reinvestment, and undermine long-term shareholder returns.
Deteriorating Cash GenerationA sharp decline in free cash flow reduces internal funding for capital expenditure, working capital and debt service. Weak cash generation increases reliance on external financing, raising vulnerability to higher borrowing costs and limiting the firm's ability to invest or pursue expansion sustainably.
Exposure To Input And Price VolatilityBusiness economics are structurally sensitive to raw material and ASP swings common in glove manufacturing. Without durable pricing power, input or logistics cost spikes can compress margins and cash flow unpredictably, requiring active risk management or margin levers to stabilize results.
UG Healthcare Corp. Ltd. News
8K7 FAQ
What was UG Healthcare Corp. Ltd.’s price range in the past 12 months?
UG Healthcare Corp. Ltd. lowest share price was S$0.09 and its highest was S$0.12 in the past 12 months.
What is UG Healthcare Corp. Ltd.’s market cap?
UG Healthcare Corp. Ltd.’s market cap is S$58.02M.
When is UG Healthcare Corp. Ltd.’s upcoming earnings report date?
UG Healthcare Corp. Ltd.’s upcoming earnings report date is Aug 31, 2026 which is in 191 days.
How were UG Healthcare Corp. Ltd.’s earnings last quarter?
UG Healthcare Corp. Ltd. released its earnings results on Feb 11, 2026. The company reported -S$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -S$0.002.
Is UG Healthcare Corp. Ltd. overvalued?
According to Wall Street analysts UG Healthcare Corp. Ltd.’s price is currently Overvalued.
Does UG Healthcare Corp. Ltd. pay dividends?
UG Healthcare Corp. Ltd. pays a Notavailable dividend of S$0.003 which represents an annual dividend yield of N/A. See more information on UG Healthcare Corp. Ltd. dividends here
What is UG Healthcare Corp. Ltd.’s EPS estimate?
UG Healthcare Corp. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does UG Healthcare Corp. Ltd. have?
UG Healthcare Corp. Ltd. has 623,825,800 shares outstanding.
What happened to UG Healthcare Corp. Ltd.’s price movement after its last earnings report?
UG Healthcare Corp. Ltd. reported an EPS of -S$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of UG Healthcare Corp. Ltd.?
Currently, no hedge funds are holding shares in SG:8K7
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
UG Healthcare Corp. Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.00%
12-Months-Change
Fundamentals
Return on Equity
-2.33%
Trailing 12-Months
Asset Growth
4.43%
Trailing 12-Months
Company Description
UG Healthcare Corp. Ltd.
UG Healthcare Corp. Ltd. (8K7) is a prominent player in the healthcare sector, primarily focused on the manufacturing and distribution of medical gloves and other healthcare-related products. The company operates in various markets, providing essential products to hospitals, clinics, and healthcare providers worldwide. With a commitment to quality and innovation, UG Healthcare has established a strong reputation for its nitrile and latex gloves, catering to both the medical and industrial sectors.
Technical Analysis
Riverstone Holdings
―
Hyphens Pharma International Ltd.
―
Medtecs International Corporation Ltd.
―
Pharmesis International Ltd.
―
―